Tempus AI Buys Personalis in $1.5B Deal to Advance Blood-Based Cancer Detection
The deal combines advanced cancer diagnostics with Tempus’ AI platform for improved surveillance.
/ 220 items
#andre↓
Seaport Downgrades Birkenstock to Neutral on Weak Q2 Retail Demand
Seaport downgraded Birkenstock as weaker Q2 sales, fewer store orders, and economic pressures may hurt near-term growth.
Alibaba’s Qwen 3.8 Max Challenges AI Frontier as Chinese Models Surge
Alibaba’s new 2.4T-parameter Qwen 3.8 Max claims second place behind Anthropic’s Fable 5. Shares surged as China’s AI race intensifies with Moonshot’s Kimi K3.
Abivax Re-Engages Centerview as It Eyes Major Pharma Partnerships After $874M Raise
Abivax has resumed partnership talks with major pharma companies via Centerview Partners while preparing a potential independent U.S. launch of obefazimod.
Meta in Early Talks to Lease $10 Billion AI Compute Capacity to Anthropic
The move could create a new revenue stream for Meta while helping Anthropic reduce reliance on its existing SpaceX contract.
Seaport Downgrades Sonic Automotive to Neutral on Valuation Concerns
The firm remains constructive on the auto retail sector.